WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2016

Feb 25, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2016-02-23

Reporting Person: Lennartz Heino (President Europe)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-23	Common Stock	A	3171.0000	$59.6400	Acquired	30666.0285	Direct

Footnotes

F1: Shares represent the portion of the Performance Share Unit Award granted in 2013 that have vested for period 12.